Peptides, Explained: Why the One Trial Everyone Cites Used 0.0003%

What a peptide actually is

A peptide is a short chain of amino acids. Proteins are long chains; peptides are fragments. Skin is full of proteins — collagen, elastin, keratin — and the whole idea behind cosmetic peptides is that a fragment of a protein can act as a message rather than a building block.

The best-studied example makes this concrete. KTTKS is a five-amino-acid sequence (lysine-threonine-threonine-lysine-serine) taken from type I procollagen. In skin, fragments like this appear when collagen is broken down, and their presence is one of the signals that more collagen is needed. The cosmetic proposition is to supply that fragment topically and let the skin read it as a signal.

Whether that message survives the trip through the stratum corneum is the entire question, and it is why the next section exists.

The "palmitoyl" prefix is doing half the work

You will almost never see plain KTTKS on an ingredient list. You will see palmitoyl pentapeptide-4. The palmitoyl part is a fatty acid chain attached to the peptide, and it is not decorative.

Peptides are water-loving and comparatively large. The outer layer of skin is lipid-rich and selects against exactly those properties. Attaching a palmitic acid tail makes the molecule more lipophilic — more compatible with the barrier it has to cross. Nearly every peptide that reached commercial use carries one of these modifications: palmitoyl, acetyl, myristoyl. When you see those prefixes, you are looking at a delivery decision, not a different active.

This is also the honest limit of the category. Penetration is improved by these tails, not solved by them, and how much peptide reaches living tissue in a given formula is rarely published.

The one trial everyone cites

The study behind palmitoyl pentapeptide-4 is Robinson and colleagues, published in the International Journal of Cosmetic Science in June 2005 (volume 27, pages 155–160). It is worth knowing in detail, because it is quoted constantly and described accurately almost never.

• Design — 12 weeks, double-blind, placebo-controlled, split-face, left-right randomised
• Subjects — 93 Caucasian women, aged 35 to 55
• Comparison — a moisturiser control versus the same moisturiser containing 3 ppm pal-KTTKS
• Result — well tolerated, with significant improvement versus placebo in wrinkles and fine lines by both quantitative image analysis and expert grader assessment; subjects also reported significant fine line and wrinkle improvement in self-assessment

Two caveats belong with those numbers. The split-face design is a genuine strength — each subject is her own control. The authors were at Procter & Gamble's Miami Valley Laboratories, meaning this is manufacturer research, which is normal in cosmetic science and still worth stating out loud. And the comparator was a moisturiser, not a retinoid.

Why 3 ppm makes "percentage" the wrong question

Three parts per million is 0.0003%. Compare that to niacinamide, which was measured at 2%, 5% and 10% — a range where doubling the number is a real change you can reason about.

Peptides do not work that way. They are studied at ppm because they are proposed to act as signals, and a signal does not scale like a solvent. This has three consequences for shopping:

• A high advertised peptide percentage is not evidence of a better product. Most "peptide complex 10%" claims refer to a supplier's pre-diluted trade blend, where the peptide itself is a tiny fraction of that figure.
• Ingredient-list position is close to meaningless here. An active used at 0.0003% will always sit near the end of the list, next to preservatives.
• The specific INCI name matters more than any number. Palmitoyl pentapeptide-4 and palmitoyl tripeptide-1 are different molecules with different literature behind them.

The second family works on a different mechanism

Acetyl hexapeptide-8 (often sold as Argireline) is not a signal peptide. It is proposed to interfere with the vesicle machinery involved in neurotransmitter release at the neuromuscular junction — the reason it is marketed with comparisons to injectables, which it does not earn.

The concentration story here is the opposite of pal-KTTKS. The Cosmetic Ingredient Review's safety assessment cites a study in which 10 healthy women applied an oil-in-water emulsion containing 10% acetyl hexapeptide-8 amide twice daily for 30 days, with reported reductions in wrinkle depth of roughly 20% by day 15 and about 30% by day 30.

Read that sample size again. Ten subjects, no placebo arm described, and a 10% use level — three orders of magnitude above pal-KTTKS. It is a plausible signal, not a settled result, and it is not comparable to the 93-subject split-face design above.

Copper peptides are the oldest and the least settled

Copper tripeptide-1, or GHK-Cu, has the longest history of the three — it was identified in human plasma in the 1970s and has a substantial wound-healing literature. The cosmetic claims are broader than that literature: skin density, elasticity, and texture over roughly 12-week periods, generally from small studies with varied designs and outcome measures.

Two practical points. First, the copper complex is coloured, which is why these products are blue and why the shade is not a purity indicator. Second, the widely repeated instruction never to use copper peptides alongside vitamin C or direct acids rests on plausible chemistry — a redox-active metal complex next to a strong reducing agent — rather than on published evidence of a clinical problem in finished formulas. If you want to separate them, alternate mornings and evenings. That costs nothing and is easier to follow than a rule nobody has tested.

What peptides are, and are not, an alternative to

The strongest honest claim for peptides is tolerability. They do not irritate, they do not photosensitise, and they can be used on skin that cannot cope with stronger actives. That is a real advantage, particularly next to retinoids, which the EU capped at 0.3% in leave-on facial products precisely because their activity comes with a tolerability cost.

What that advantage does not buy is equivalence. The retinoid literature is far larger and far older than the peptide literature. Peptides sit closer to adenosine — actives with specific, modest, measurable effects on the appearance of lines, tested over 8 to 12 weeks. Expecting more than that from any peptide is expecting more than has been measured.

Reading a peptide label without guessing

Four things to check, in order:

• Find the specific INCI name. Palmitoyl pentapeptide-4, acetyl hexapeptide-8, copper tripeptide-1. If the label only says "peptide complex," there is nothing to look up.
• Ignore the headline percentage unless the brand states the actual peptide concentration rather than the trade-blend concentration. Most do not.
• Check the format. Peptides are usually water-phase and go in a serum or essence layer, which places them after cleansing and before heavier occlusives in the standard order.
• Give it 12 weeks. The trial that established the category ran 12 weeks. Judging a peptide serum at three is judging the moisturiser it came in.

Sources. Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. "Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin." International Journal of Cosmetic Science 2005;27(3):155–160 (93 Caucasian female subjects aged 35–55; 12-week double-blind, placebo-controlled, split-face, left-right randomised design; moisturiser control versus the same moisturiser containing 3 ppm pal-KTTKS); Cosmetic Ingredient Review safety assessment of acetyl hexapeptide-8, citing a 30-day study of an oil-in-water emulsion containing 10% acetyl hexapeptide-8 amide applied twice daily by 10 healthy women; European Commission Regulation (EU) 2024/996 for the 0.3% retinol limit in leave-on facial products. Copper tripeptide-1 claims are drawn from small studies with varied designs and are described here as unsettled rather than established. Verified August 2026. Patch-test any new product on a small area before applying it broadly, and see a dermatologist for any skin condition that is persistent, painful or changing.